CN Patent

CN116323579B — 1H-吡咯并[2,3-c]吡啶类化合物及其应用

Assigned to Chengdu Jiabao Pharmaceutical Silver Pharmaceutical Technology Co ltd · Expires 2024-04-05 · 2y expired

What this patent protects

一系列1H‑吡咯并[2,3‑c]吡啶类化合物及其应用，具体公开了式(P)所示化合物及其药学上可接受的盐。

USPTO Abstract

一系列1H‑吡咯并[2,3‑c]吡啶类化合物及其应用，具体公开了式(P)所示化合物及其药学上可接受的盐。

Drugs covered by this patent

pexidartinib-hydrochloride (PEXIDARTINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CN116323579B
Jurisdiction: CN
Classification: —
Expires: 2024-04-05
Drug substance claim: No
Drug product claim: No
Assignee: Chengdu Jiabao Pharmaceutical Silver Pharmaceutical Technology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.